CURI vs NXST

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 17, 2026

CURI

46.9
AI Score
VS
NXST Wins

NXST

53.3
AI Score

Investment Advisor Scores

CURI

47score
Recommendation
BUY

NXST

53score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric CURI NXST Winner
Forward P/E 9.0334 9.058 CURI
PEG Ratio 0 0.2875 Tie
Revenue Growth 22.3% 62.2% NXST
Earnings Growth 1400.0% 18.0% CURI
Tradestie Score 46.9/100 53.3/100 NXST
Profit Margin 0.0% 3.2% NXST
Beta 1.00 1.00 Tie
AI Recommendation BUY HOLD CURI

Relative Price Performance (Last 90 Days)

CURI 1M: -0.3% · 3M: +3.4% NXST 1M: -12.3% · 3M: -15.0%

Current Technical Phase

CURI

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (2.8% over 20 days), RSI 53

RSI (14): 52.8 · Price: $2.91

NXST

Markdown
Sell / avoid

Price below a falling SMA50 (slope -2.8%), weak momentum, RSI 32

RSI (14): 32.4 · Price: $155.42

Fundamentals Snapshot

Metric CURI NXST
Market Cap — —
Forward P/E 9.4 6.7
Trailing P/E — 30.1
Revenue (TTM) — —
Revenue Growth 0.2% 0.6%
Gross Margin 0.6% 0.6%
Operating Margin 0.4% 0.2%
EPS -0.01 5.27
Dividend Yield 0.11% 0.05%

Frequently Asked Questions

Based on our detailed analysis, NXST is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.